Share Prices & Company Research

Stockbroking

Diurnal Group

Current Price 30.00p Bid 30.00p Ask 32.00p Change -3.13%
Last Updated: 25/05/2019 07:15. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Diurnal Group plc is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

Financial Highlights Year Ended 30/06/2018

Turnover
£0.07m
Operating Profit
£-16.78m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-1.19

Key Personnel

Dr Martin James Whitaker
Chief Executive Officer
Richard Edward Bungay
Chief Financial Officer
Prof Richard John Martin Ross
Chief Scientific Officer
Peter Vance Allen
Non-Executive Chairman
Dr Samuel Cameron Williams
Non-Executive Director
Dr Alan Michael Raymond
Non-Executive Director
John Geoffrey Goddard
Non-Executive Director

Stock Details

EPIC
DNL
ISIN
GB00BDB6Q760
Shares in Issue
61,721,880
Market cap
£19.75m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
31.00p
Bid Price
30.00p
Ask Price
32.00p
Volume
24077
Change Today
-1.00p
% Change Today
-3.13%
Open
31.00p
Previous Close
31.00p
Intraday High
31.00p
Intraday Low
30.00p
52 Week High
196.00p
52 Week Low
21.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Diurnal Group Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
0.0
0.0
Inventory
0.1
0.0
Trade & Receivables
5.1
4.0
Cash & Receivables
17.3
8.9
Other Current Assets & Assets Held for Resale
0.0
11.0
Total Assets
22.5
23.9

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Short Term Liabilities
5.7
3.3
Long Term Liabilities
0.0
3.5
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
5.7
6.9

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Net Assets
16.9
17.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Share Capital
3.1
2.6
Minority Interests
0.0
0.0
Retained Earnings
-21.0
-7.7
Share Premium Account
37.8
23.7
Other Equity
-2.9
-1.5
Total Equity
16.9
17.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Cashflow from Operating Activities
-12.8
-10.5
Cashflow Before Financing
-1.7
-7.3
Increase / Decrease in Cash
8.2
-7.2

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Turnover
0.1
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.1
0.0
Operating Profit
-16.8
-12.1
Pre-Tax Profit
-16.9
-12.2
Profit / Loss for the Year
-14.6
-9.4
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.